Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 14 Obesity 2 Disease 2 Prostatic Neoplasms 1 Obesity, Morbid 1 Neoplasms 1 Hypersensitivity 1 Cysts 1 Colorectal Neoplasms 1 Carcinoma, Intraductal, Noninfiltrating 1 Acquired Immunodeficiency Syndrome 1

Interventions

Exercise 19 Drug Therapy 18 pembrolizumab 13 Capecitabine 11 Blood Specimen Collection 11 Surveys and Questionnaires 10 Radiotherapy 10 Paclitaxel 9 Dexamethasone 9 Nivolumab 8 Standard of Care 7 Oxaliplatin 7 Fluorouracil 7 Erlotinib Hydrochloride 7 apatinib 6 Interviews as Topic 6 Gemcitabine 6 Control Groups 6 Cisplatin 6 Therapeutics 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Injections 5 Everolimus 5 Docetaxel 5 Cyclophosphamide 5 Bevacizumab 5 sintilimab 4 atezolizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × Mammography × Clear all

NCT04735445 2021-02-03

IMPACNEO

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Phase NA Unknown

Acquired Immunodeficiency Syndrome, Disease, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡